AI assistant
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024
Aug 20, 2024
35599_dirs_2024-08-19_5d0b531c-f7bb-4530-9ada-a220e07c6eb5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-08-15
Reporting Person: Hackman Jeffrey S. (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options | $5.58 | 2034-08-05 | Common Shares (400000) | Direct |
Footnotes
F1: On August 15, 2024, Jeffrey Hackman was granted incentive stock options to purchase 400,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F2: One-third of the shares subject to this option may be exercised as of August 5, 2025 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of August 5, 2027, 100% of the total number of shares subject to this option shall be vested.